Literature DB >> 29509749

Stimulus package.

.   

Abstract

Mesh：

Year:  2018        PMID： 29509749     DOI： 10.1038/nm.4515

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.

Authors:  Ron Brookmeyer; Nada Abdalla; Claudia H Kawas; María M Corrada
Journal:  Alzheimers Dement       Date:  2017-12-07       Impact factor: 21.566

2.  Alzheimer's disease drug-development pipeline: few candidates, frequent failures.

Authors:  Jeffrey L Cummings; Travis Morstorf; Kate Zhong
Journal:  Alzheimers Res Ther       Date:  2014-07-03       Impact factor: 6.982

3.  Economic analysis of opportunities to accelerate Alzheimer's disease research and development.

Authors:  Troy J Scott; Alan C O'Connor; Albert N Link; Travis J Beaulieu
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691
  3 in total
  6 in total

Review 1.  Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.

Authors:  Klaus Grossmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 2.  Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin.

Authors:  Toshihiko Tashima
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

Review 3.  Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.

Authors:  Toshihiko Tashima
Journal:  Pharmaceutics       Date:  2022-02-14       Impact factor: 6.321

Review 4.  Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates.

Authors:  Toshihiko Tashima
Journal:  Biomedicines       Date:  2022-07-05

Review 5.  Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling.

Authors:  Florencia Andrea Ceppa; Luca Izzo; Lorenzo Sardelli; Ilaria Raimondi; Marta Tunesi; Diego Albani; Carmen Giordano
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

6.  Anticoagulants for Treatment of Alzheimer's Disease.

Authors:  Klaus Grossmann
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.